Profitability
Weight: 20%
F
7
- 5yr Avg ROIC 0.0%
- Operating Margin Trend -631.50 pp/yr
RNAC
Cartesian Therapeutics, Inc.
AlphaQuality composite grade, weighted for stable earnings power businesses.
⚠ 4 of the last 5 fiscal years showed negative net income — AlphaQuality will not grade above F for persistent unprofitability in a stable earnings power business.
Grade overrides the 20.8 pillar composite — hard gates always win.
Capital Efficiency
Weight: 15%
F
6
- 5yr Avg ROE 0.0%
- 5yr Share-Count CAGR 69.1%
Growth Quality
Weight: 15%
F
19
- 5yr Revenue CAGR -57.4%
- 5yr EPS CAGR 0.0%
- Revenue-Growth Years (5) 3/5
Cash Generation
Weight: 15%
F
0
- 5yr FCF Margin -644.4%
- 5yr FCF/NI Conversion -0.93x
Balance Sheet
Weight: 20%
D-
30
- Net Debt / EBITDA 10.00x
- Interest Coverage (EBIT/Int) 30.00x
- Altman Z-Score -4.22
Stability
Weight: 15%
B-
63
- EPS Volatility (σ/μ) 0.00
- Piotroski F-Score 1
- Negative-Revenue Years (5) 2/5
Guru Flow
Curated superinvestor sentiment — not part of the AlphaQuality grade.Not enough curated-guru data to call a flow.
- Wood sold -100%